Limb Preservation Platform

Executive Summary

Limb Preservation Platform (LPP) is a specialized clinical research center headquartered in San Antonio, Texas, exclusively focused on limb preservation for patients with diabetic foot and lower leg wounds. Founded in 2018, LPP operates as a comprehensive Phase I-IV facility, partnering with pharmaceutical and medical device sponsors to conduct clinical trials that generate pivotal data for novel therapies and technologies. By concentrating on a high-need, underserved area of vascular and wound care, LPP offers its sponsors access to a dedicated patient population and deep expertise in limb salvage, potentially reducing trial timelines and improving outcomes. The company's niche positioning in a growing market—driven by rising diabetes prevalence and an aging population—positions it as a valuable partner for developing advanced wound care solutions. With no disclosed funding or revenue, LPP's success hinges on its ability to secure and execute trials for major sponsors.

Upcoming Catalysts (preview)

• Q3 2026New Sponsor Contract for Phase III Diabetic Wound Trial70% success
• Q1 2027Publication of Positive Data from Completed Phase II Study60% success
• nullExpansion of Facility or Services into Adjacent Indications40% success